Skip to content

What is the drug ranitidine used for? Exploring its history and recall

4 min read

In April 2020, the U.S. Food and Drug Administration (FDA) requested the withdrawal of all prescription and over-the-counter ranitidine drugs from the market due to unacceptable levels of a cancer-causing impurity. Before this, the drug ranitidine was used for a variety of conditions related to excess stomach acid, including the treatment and prevention of stomach and duodenal ulcers.

Quick Summary

Ranitidine, formerly known by the brand name Zantac, was an H2 blocker used to treat conditions like stomach ulcers and GERD by reducing acid production before being recalled due to NDMA contamination.

Key Points

  • Former Use: Ranitidine was used to treat and prevent stomach ulcers and gastroesophageal reflux disease (GERD) by reducing stomach acid.

  • Recall: The FDA requested a full market withdrawal of all ranitidine products in April 2020 due to contamination with N-nitrosodimethylamine (NDMA), a probable human carcinogen.

  • Mechanism of Action: As a histamine-2 (H2) blocker, ranitidine worked by inhibiting histamine at the H2-receptors in the stomach, which are responsible for secreting acid.

  • Alternative Medications: Safer alternatives for managing acid-related issues include other H2 blockers (like famotidine) and Proton Pump Inhibitors (PPIs) (like omeprazole).

  • NDMA Safety Concerns: The NDMA impurity in some ranitidine products was found to increase over time, posing an unacceptable level of risk to consumers.

  • Zollinger-Ellison Syndrome: Ranitidine was also used to manage pathological hypersecretory conditions, such as Zollinger-Ellison syndrome, where the stomach produces excessive acid.

  • Historical Brand Name: Ranitidine was commonly known by its brand name, Zantac, which has since been reformulated with a different active ingredient (famotidine).

In This Article

Historical Therapeutic Uses of Ranitidine

Before its global withdrawal, ranitidine was a popular and effective medication for managing a range of conditions related to the overproduction of stomach acid. As an H2 (histamine-2) blocker, its primary function was to reduce gastric acid secretion. Its applications were extensive, addressing both common and more serious gastrointestinal issues.

Peptic Ulcers

Ranitidine was commonly prescribed for the treatment and maintenance of peptic ulcers, which include both gastric (stomach) and duodenal (small intestine) ulcers. By reducing the amount of acid in the stomach, ranitidine allowed the protective lining of the digestive tract to heal. Treatment typically lasted for a few weeks to address an active ulcer, with a lower dose sometimes prescribed for maintenance to prevent recurrence.

Gastroesophageal Reflux Disease (GERD) and Heartburn

Gastroesophageal reflux disease (GERD) is a condition where stomach acid flows back into the esophagus, causing heartburn and potential damage to the esophageal lining. Ranitidine was widely used to treat and manage GERD symptoms. For individuals with occasional heartburn or acid indigestion, over-the-counter (OTC) versions of ranitidine were available and often taken 30 to 60 minutes before eating foods that triggered symptoms. For more severe cases, a prescription-strength dosage was used to help heal erosive esophagitis, which is the inflammation and damage to the esophageal lining caused by chronic acid exposure. Clinical studies demonstrated that ranitidine therapy significantly reduced heartburn symptoms and improved the endoscopic appearance of the esophageal mucosa.

Pathological Hypersecretory Conditions

In addition to general acid-related issues, ranitidine was used for more serious conditions where the stomach produced an excessive amount of acid. One such condition is Zollinger-Ellison syndrome, a rare disorder that causes tumors to form in the pancreas or small intestine, leading to high acid levels. Ranitidine helped manage these extreme acid secretions.

Other Uses

Ranitidine also had several other medical applications, including:

  • Prevention of NSAID-Induced Ulcers: It was sometimes used to prevent ulcers in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs), although more potent proton pump inhibitors (PPIs) were considered more effective.
  • Upper Gastrointestinal Bleeding: The drug was used as part of the treatment for upper GI bleeding.
  • Stress Ulcer Prophylaxis: In critically ill patients, ranitidine was used to prevent the formation of stress-induced ulcers.
  • Prevention of Aspiration Pneumonitis: It could be administered before surgery to reduce the risk of patients aspirating stomach acid during anesthesia.

The Ranitidine Recall: NDMA Contamination and Safety Concerns

In 2019, an online pharmacy called Valisure reported finding N-nitrosodimethylamine (NDMA) in ranitidine products. NDMA is classified as a probable human carcinogen, meaning it could potentially cause cancer. Subsequent testing by the FDA confirmed that the NDMA impurity in some ranitidine products could increase over time and when stored at higher than room temperatures. The discovery prompted voluntary recalls by several manufacturers, and by April 2020, the FDA requested that all manufacturers withdraw ranitidine from the U.S. market. As a result, ranitidine products are no longer available for new or existing prescriptions or over-the-counter use in the United States.

Alternatives to Ranitidine

For those who previously relied on ranitidine for acid-related issues, several alternatives are available. The FDA's preliminary tests of these alternatives have not shown NDMA contamination.

  • Other H2 Blockers: These medications work similarly to ranitidine by blocking histamine receptors. Alternatives include famotidine (Pepcid) and cimetidine (Tagamet). Famotidine, in particular, is often recommended as a substitute.
  • Proton Pump Inhibitors (PPIs): PPIs are generally more potent at reducing stomach acid and include drugs such as omeprazole (Prilosec), esomeprazole (Nexium), and lansoprazole (Prevacid).
  • Antacids: For milder, occasional heartburn relief, antacids can neutralize stomach acid.
  • Lifestyle Changes: Avoiding certain foods and drinks (e.g., spicy or fatty foods, alcohol, caffeine) and making dietary adjustments can also help manage heartburn and acid reflux.

Comparing Ranitidine to a Modern Alternative (Famotidine)

Feature Ranitidine (Historical) Famotidine (Current)
Drug Class H2 Blocker H2 Blocker
Availability Withdrawn from market due to NDMA contamination Widely available, considered safer
Potency Less potent on an equimolar basis Up to 9 times more potent on an equimolar basis
Duration of Action Relatively shorter duration About 30% longer duration of action
NDMA Risk Found to contain NDMA impurity, a probable carcinogen Not linked to NDMA contamination issues

Conclusion: The Shift Away from Ranitidine

Ranitidine was a cornerstone medication for treating and preventing acid-related digestive disorders like ulcers and GERD for decades. Its mechanism of action, which involves blocking histamine H2-receptors, was highly effective in reducing stomach acid production. However, the discovery of NDMA contamination, a probable human carcinogen, led to its definitive removal from the market. This significant safety concern necessitated a transition for millions of users to alternative treatments. The market withdrawal spurred a pivot towards other H2 blockers, such as famotidine, and more potent proton pump inhibitors, ensuring that patients could continue to manage their conditions effectively and safely. The story of ranitidine serves as a crucial reminder of the ongoing nature of pharmaceutical safety monitoring and the importance of adapting medical practice as new information emerges.

Frequently Asked Questions

Ranitidine was recalled because it was found to contain unacceptable levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen, which increased over time, especially when stored at higher temperatures.

Historically, ranitidine was used to treat and prevent peptic ulcers (gastric and duodenal), gastroesophageal reflux disease (GERD), heartburn, and other conditions involving excess stomach acid like Zollinger-Ellison syndrome.

NDMA stands for N-nitrosodimethylamine, a probable human carcinogen. The presence of this impurity in ranitidine raised safety concerns about an increased risk of cancer for those taking the medication.

The FDA recommends properly disposing of any ranitidine tablets or other products you may have and not purchasing them anymore. You should speak with a healthcare provider about alternative treatment options for your condition.

Common alternatives include other H2 blockers like famotidine (Pepcid) and cimetidine (Tagamet), as well as Proton Pump Inhibitors (PPIs) like omeprazole (Prilosec), esomeprazole (Nexium), and lansoprazole (Prevacid).

No. The old Zantac contained ranitidine. Following the recall, the brand reformulated Zantac 360 with a different active ingredient, famotidine, which is considered a safe alternative.

Ranitidine functioned as an H2 blocker. It worked by competitively and reversibly inhibiting histamine at the H2-receptors on the stomach's parietal cells, thereby reducing the volume and concentration of gastric acid secreted.

According to the FDA, preliminary tests on alternative medications such as Pepcid (famotidine) and Tagamet (cimetidine) have shown no NDMA contamination. NDMA contamination was identified specifically in ranitidine and nizatidine products.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.